Listeria monocytogenes Strain-Specific Impairment of the TetR Regulator Underlies the Drastic Increase in Cyclic di-AMP Secretion and Beta Interferon-Inducing Ability

被引:38
作者
Yamamoto, Takeshi [1 ]
Hara, Hideki [1 ]
Tsuchiya, Kohsuke [1 ]
Sakai, Shunsuke [1 ]
Fang, Rendong [1 ]
Matsuura, Motohiro [1 ]
Nomura, Takamasa [2 ]
Sato, Fumihiko [3 ]
Mitsuyama, Masao [1 ]
Kawamura, Ikuo [1 ]
机构
[1] Kyoto Univ, Grad Sch Med, Dept Microbiol, Kyoto, Japan
[2] Jin Ai Univ, Fac Hlth & Nutr, Fukui, Japan
[3] Kyoto Univ, Grad Sch Biostudies, Dept Plant Gene & Totipotency, Kyoto, Japan
基金
日本学术振兴会;
关键词
CYTOSOLIC SURVEILLANCE PATHWAY; INNATE IMMUNE-RESPONSE; HOST-DEFENSE; RIG-I; INFECTION; RECEPTOR; ACTIVATION; INDUCTION; BACTERIA; IFN;
D O I
10.1128/IAI.06162-11
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Among a number of laboratory strains of Listeria monocytogenes used in experimental infection, strain LO28 is highly capable of inducing robust beta interferon (IFN-beta) production in infected macrophages. In this study, we investigated the molecular mechanism of the IFN-beta-inducing ability of LO28 by comparing it with that of strain EGD, a low-IFN-beta-inducing strain. It was found that LO28 secretes a large amount of IFN-beta-inducing factor, which turned out to be cyclic di-AMP. The secretion of cyclic di-AMP was dependent on MdrT, a multidrug resistance transporter, and LO28 exhibited a very high level of mdrT expression. The introduction of a null mutation into mdrT abolished the ability of LO28 to induce IFN-beta production. Examination of genes responsible for the regulation of mdrT expression revealed a spontaneous 188-bp deletion in tetR of LO28. By constructing recombinant strains of LO28 and EGD in which tetR from each strain was replaced, it was confirmed that the distinct ability of LO28 is attributable mostly to tetR mutation. We concluded that the strong IFN-beta-inducing ability of LO28 is due to a genetic defect in tetR resulting in the overexpression of mdrT and a concomitant increase in the secretion of cyclic di-AMP through MdrT.
引用
收藏
页码:2323 / 2332
页数:10
相关论文
共 54 条
[1]   Toll-like receptor signalling [J].
Akira, S ;
Takeda, K .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) :499-511
[2]   Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes [J].
Auerbuch, V ;
Brockstedt, DG ;
Meyer-Morse, N ;
O'Riordan, M ;
Portnoy, DA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (04) :527-533
[3]   Listeriosis: a primer [J].
Bortolussi, Robert .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2008, 179 (08) :795-797
[4]   Type I interferon sensitizes lymphocytes to apoptosis and reduces resistance to listeria infection [J].
Carrero, JA ;
Calderon, B ;
Unanue, ER .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 200 (04) :535-540
[5]   The potential of 3′,5′-cyclic diguanylic acid (c-di-GMP) as an effective vaccine adjuvant [J].
Chen, Wangxue ;
KuoLee, Rhonda ;
Yan, Hongbin .
VACCINE, 2010, 28 (18) :3080-3085
[6]   Listeria monocytogenes multidrug resistance transporters activate a cytosolic surveillance pathway of innate immunity [J].
Crimmins, Gregory T. ;
Herskovits, Anat A. ;
Rehder, Kai ;
Sivick, Kelsey E. ;
Lauer, Peter ;
Dubensky, Thomas W., Jr. ;
Portnoy, Daniel A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (29) :10191-10196
[7]   The Yin and Yang of type I interferon activity in bacterial infection [J].
Decker, T ;
Müller, M ;
Stockinger, S .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (09) :675-687
[8]   Listeriosis: clinical presentation [J].
Doganay, M .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2003, 35 (03) :173-175
[9]   Antimicrobial mechanisms of phagocytes and bacterial evasion strategies [J].
Flannagan, Ronald S. ;
Cosio, Gabriela ;
Grinstein, Sergio .
NATURE REVIEWS MICROBIOLOGY, 2009, 7 (05) :355-366
[10]   Human Toll-like receptor 2 mediates monocyte activation by Listeria monocytogenes, but not by group B streptococci or lipopolysaccharide [J].
Flo, TH ;
Halaas, O ;
Lien, E ;
Ryan, L ;
Teti, G ;
Golenbock, DT ;
Sundan, A ;
Espevik, T .
JOURNAL OF IMMUNOLOGY, 2000, 164 (04) :2064-2069